Search results for "HIV+"

showing 10 items of 1527 documents

Serological pattern of Hepatitis B, C, and HIV infections among immigrants in Sicily: epidemiological aspects and implication on public health.

2011

The objective of this study was to describe the prevalence of Hepatitis B virus (HBV), Hepatitis C virus (HCV), and human immunodeficiency virus (HIV) infections in a cohort of immigrants living in Palermo, Sicily. The study was carried out in the period May 2006-June 2010 and recruited a total of 393 patients (59.8% males-median age of 32.6 years). All patients were tested for serological markers of HBV, HCV, and HIV infection. One-hundred thirty-eight (35.1%) individuals did not show any HBV/HCV/HIV serological marker, while 186 (47.3%) were indicative of past or current HBV infection. A total of 42 (10.7%) subjects were HBsAg positive, 59 (15.0%) showed the serological profile "anti-HBc …

AdultMaleHBsAgmedicine.medical_specialtyHealth (social science)HIV AntigensHepatitis C virusEmigrants and ImmigrantsHIV InfectionsSettore MED/42 - Igiene Generale E Applicatamedicine.disease_causeEpidemiologymedicinePrevalenceHumansHuman immunodeficiencySicilyRetrospective StudiesHepatitis B virusHepatitis B Surface Antigensbusiness.industryPublic healthPublic Health Environmental and Occupational Healthvirus diseasesHepatitis CHepatitis BMiddle Agedmedicine.diseaseHepatitis BVirologyHepatitis B Core AntigensHepatitis Cdigestive system diseasesCross-Sectional StudiesCohortFemalePublic HealthHepatitis C AntigensbusinessBiomarkersImmigrantJournal of community health
researchProduct

Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B

2013

Treatment with peginterferon α-2a (PegIFN) for 48 weeks is the standard of care for selected HBeAg-negative patients chronically infected with hepatitis B virus (HBV), but with limited treatment efficacy. A study was undertaken to investigate whether treatment extension to 96 weeks improves the outcome in this patient population.128 HBeAg-negative patients (120 genotype D) were randomised to weekly 180 μg PegIFN for 48 weeks (group A, n=51), 180 μg PegIFN for 48 weeks followed by 135 μg weekly for an additional 48 weeks (group B, n=52) or 180 μg PegIFN plus lamivudine (100 mg/day) for 48 weeks then 135 μg PegIFN for 48 weeks (group C, n=25). Endpoints were alanine aminotransferase normalisa…

AdultMaleHBsAgmedicine.medical_specialtyHepatitis B virusTime FactorsAnti-HIV Agentsmedicine.disease_causeGastroenterologyAntiviral AgentsGroup Blaw.inventionPolyethylene GlycolsPharmacotherapyHepatitis B ChronicRandomized controlled triallawPegylated interferonInternal medicinemedicineHumansHepatitis B e AntigensHepatitis B virusbusiness.industryGastroenterologyLamivudineInterferon-alphaAlanine TransaminaseHepatitis BMiddle Agedmedicine.diseaseHepatitis BRecombinant ProteinsTreatment OutcomeLamivudineImmunologyDNA ViralInterferonDrug Therapy CombinationFemaleHepatitis B; Interferonbusinessmedicine.drug
researchProduct

Socio-Demographic Characteristics and Sexual Behavioral Factors of Patients with Sexually Transmitted Infections Attending a Hospital in Southern Ita…

2021

Sexually transmitted infections (STIs) are a serious global health problem. In Italy, data describing the vulnerability to STIs of specific sexual minorities and the influence of sociodemographic and behavioral determinants are limited, as most infections are not subject to mandatory notification. This retrospective study describes the sociodemographic profile and main sexual behaviors of patients attending a hospital in Palermo (Sicily, Italy) from January 2018 to March 2019 as predictors of STI risk. Patients were divided in subgroups: men-who-have-sex-with-men (MSM), men-who-have-sex-with-women (MSW), bisexual men and females. Data were obtained through an anonymous questionnaire. Patien…

AdultMaleHPVSexual BehaviorHealth Toxicology and MutagenesisSocio demographicsSexually Transmitted DiseasessyphilisHIV InfectionsMycoplasma genitaliumSTIsArticleSexual and Gender Minorities03 medical and health sciences0302 clinical medicineRisk FactorsmedicineGlobal healthHumansMycoplasma Infections030212 general & internal medicineMSMHomosexuality MaleSicilyDemographyRetrospective Studiesbehaviour risky factors HPV MSM STIs syphilis030505 public healthChlamydiabiologybusiness.industrybehaviour risky factorsPublic Health Environmental and Occupational HealthHPV infectionRvirus diseasesRetrospective cohort studymedicine.diseasebiology.organism_classificationHospitalsSexual PartnersSexual behaviorMedicineFemaleSyphilis0305 other medical sciencebusinessMycoplasma genitaliumDemography
researchProduct

Sexual behaviors in male sex workers in Spain: Modulating factors

2013

This study analyzed how the culture of origin, educational level, sexual orientation, and experience of male sex workers may mediate their commercial sexual behaviors. A total of 100 Spanish agency male sex workers were interviewed. Most of them were young men, Latin American, homosexual, and had middle-level education. Our results showed that cultural differences and sexual orientation could influence male sex workers when engaging in sexual behaviors with their clients. Social and health projects with male sex workers may have to take into account sexual myths and taboos related to sexual orientation and cultural differences.

AdultMaleHealth Knowledge Attitudes PracticeLatin AmericansAdolescentSexual Behaviorsexual healthDevelopmental psychologyYoung Adultsexual behaviorRisk-TakingAcquired immunodeficiency syndrome (AIDS)sociodemographic variablesCultural diversityAgency (sociology)medicineHumansHIV-AIDSApplied PsychologyReproductive healthSex Workersbusiness.industryHomosexualitymedicine.diseaseSexual behaviorSpainHeterosexualitySexual orientationbusinessPsychologyJournal of Health Psychology
researchProduct

Management and treatment of chronic hepatitis B virus infection in HIV positive and negative patients: The EPIB 2008 study

2010

To compare the management and the virological and serological efficacy of treatments for chronic hepatitis B (CHB) in HIV positive and negative patients.Two hundred and forty-six HIV positive and 205 HIV negative consecutive patients with past or present CHB, seen in October 2008 in participating departments, were included in a multicenter study. All the data were retrospectively collected from the first visit to October 2008 through a standardized questionnaire.Compared to HIV negative patients, HIV positive patients more often presented positive HBeAg (46.4% vs. 32.8%, p=0.01), HBV genotype A (54.8% vs. 17.1%, p0.0001), co-infection with HCV (12.4% vs. 5.9%, p=0.0002) or HDV (12.6% vs. 2.…

AdultMaleHepatitis B virusmedicine.medical_specialtyOrganophosphonatesHIV InfectionsAntiviral AgentsSerologyHepatitis B AntigensHepatitis B ChronicPharmacotherapyAcquired immunodeficiency syndrome (AIDS)Surveys and QuestionnairesInternal medicinemedicineHumansHepatitis B AntibodiesTenofovirSidaRetrospective StudiesHepatologybiologybusiness.industryAdeninevirus diseasesMiddle AgedHepatitis Bbiology.organism_classificationmedicine.diseaseHBeAgLentivirusImmunologyFemaleFranceViral diseasebusinessJournal of Hepatology
researchProduct

Epstein Barr Virus detection and latent membrane protein 1 in oral hairy leukoplakia in HIV+ Venezuelan patients

2008

Purpose: To determine the prevalence of Epstein Barr Virus (EBV) in oral hairy leukoplakia lesions (OHL) in HIV+ Venezuelan patients. Material and Method: In this case study, we evaluated 21 HIV+ adult patients with clinically present OHL lesions, 11 who were undergoing antiretroviral therapy, 10 who were not undergoing therapy and 10 HIV-negative adult patients with hyperkeratotic oral mucosal lesions. All of the subjects were assessed at the Infectious Disease Center, Faculty of Dentistry, Central University of Venezuela, and were clinically examined to detect oral mucosal lesions with the confirmed histopathologic diagnosis. Nested-PCR was used to determine the EBV infection and the late…

AdultMaleHerpesvirus 4 HumanLeukoplakia HairyHuman immunodeficiency virus (HIV)medicine.disease_causeViral Matrix ProteinsYoung Adulthemic and lymphatic diseasesHIV SeropositivityHumansMedicineYoung adultGeneral DentistryLeukoplakiaOral hairy leukoplakiabusiness.industryMiddle AgedVenezuela:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseAntiretroviral therapyEpstein–Barr virusOtorhinolaryngologyInfectious disease (medical specialty)UNESCO::CIENCIAS MÉDICASImmunologyImmunohistochemistryFemaleSurgerybusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Antibody response to human cytomegalovirus (HCMV) glycoprotein B (gB) in AIDS patients with HCMV end-organ disease

1998

Human cytomegalovirus (HCMV)-specific antibody responses in HIV-1 infected individuals either with or without HCMV end-organ disease were examined to determine the whether development of HCMV disease was associated with a particular deficit in the antibody response. Antiwhole HCMV, anti-glycoprotein B (gB), and neutralizing antibody levels were higher in HIV-1 infected individuals than in healthy immunocompetent subjects, particularly in patients with AIDS either with or without HCMV-associated disease. Irrespective of location and spread of HCMV disease, patients who had received anti-HCMV therapy prior to sampling exhibited significantly higher anti-gB and neutralizing antibody titers tha…

AdultMaleHuman cytomegalovirusAdolescentvirusesCytomegalovirusBiologyAntibodies ViralAntiviral AgentsViral Envelope ProteinsNeutralization TestsBetaherpesvirinaeVirologyImmunopathologymedicineHumansViremiaFluorescent Antibody Technique IndirectNeutralizing antibodyAcquired Immunodeficiency SyndromeAIDS-Related Opportunistic InfectionsAntibody titervirus diseasesbiochemical phenomena metabolism and nutritionmedicine.diseasebiology.organism_classificationVirologyCD4 Lymphocyte CountInfectious DiseasesImmunoglobulin GCytomegalovirus InfectionsImmunologyHIV-1biology.proteinFemaleViral diseaseAntibodyViral loadJournal of Medical Virology
researchProduct

Vaccination Against Hepatitis B Virus (HBV) in HIV-1-Infected Patients With Isolated Anti-HBV Core Antibody: The ANRS HB EP03 CISOVAC Prospective Stu…

2016

International audience;  Although an isolated anti-hepatitis B virus (HBV) core antibody (anti-HBc) serological profile is frequent in human immunodeficiency virus (HIV)-infected patients, data on HBV vaccination in these patients are scarce.  A prospective multicenter study was conducted to assess the immunogenicity of HBV vaccination in 54 patients with an isolated anti-HBc profile and undetectable HIV load. They were vaccinated with 1 dose (20 µg) of recombinant HBV vaccine. Those with an anti-HBV surface antibody (anti-HBs) level of 100 mIU/mL 4 weeks after a single recall dose of HBV vaccine should be further vaccinated with a reinforced triple double-dose scheme.

AdultMaleHuman immunodeficiency virus (HIV)HIV Infectionsmedicine.disease_causeVirusSerology03 medical and health sciences0302 clinical medicineImmunogenicity Vaccine[ SDV.MP ] Life Sciences [q-bio]/Microbiology and ParasitologyAntiretroviral Therapy Highly ActiveHepatitis B virus HBVImmunology and AllergyMedicineHumansHepatitis B Vaccines030212 general & internal medicineProspective StudiesHepatitis B AntibodiesProspective cohort study[SDV.MP] Life Sciences [q-bio]/Microbiology and ParasitologyVaccines Syntheticbiologybusiness.industryImmunogenicityvirus diseasesMiddle AgedHepatitis BVirologyHepatitis B Core Antigensdigestive system diseasesVaccinationInfectious Diseases[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyImmunologybiology.proteinHIV-1030211 gastroenterology & hepatologyFemaleAntibodybusiness
researchProduct

Validation of the German version of the ‘Hypogonadism Related Symptom Scale’ (HRS) in andrological patients with infertility, HIV infection and metab…

2013

Summary As commonly used self-reported screening instruments for male hypogonadism demonstrated lack of specificity, a Hypogonadism Related Symptom Scale (HRS) was developed in 2009 as a novel self-rating screening tool. As the questionnaire has not been validated, the purpose of our study was to perform a validation in patients presenting with different disorders (e.g. infertility, HIV infection or metabolic syndrome) and disease-related risk to develop hypogonadism. Two hundred and eighteen patients aged 19–71 years (40.1 ± 9.5) who completed the HRS and other common questionnaires [International Index Of Erectile Function (IIEF), National Institutes of Health Chronic Prostatitis Symptom …

AdultMaleInfertilitymedicine.medical_specialtyUrologyHuman immunodeficiency virus (HIV)ProstatitisHIV Infectionsmedicine.disease_causeHospital Anxiety and Depression ScaleSensitivity and SpecificitySeverity of Illness IndexYoung AdultEndocrinologyCronbach's alphaSex Hormone-Binding GlobulinSurveys and QuestionnairesInternal medicinemedicineHumansTestosteroneAgedMetabolic SyndromeGynecologybusiness.industryHypogonadismTestosterone (patch)General MedicineLuteinizing HormoneMiddle Agedmedicine.diseaseFollicle Stimulating HormoneSymptom AssessmentMetabolic syndromeLuteinizing hormonebusinessAndrologia
researchProduct

Dynamics and molecular evolution of HIV-1 strains in Sicily among antiretroviral naïve patients.

2012

Abstract HIV-1 subtype B is the most frequent strain in Sicily. To date, there is no available data about the genetic diversity of HIV-1 viral strains circulating in Sicily among antiretroviral (ARV) naive subjects and the role of immigration as potential determinant of evolutionary dynamics of HIV-1 molecular epidemiology. For this purpose, HIV-1 polymerase (pol) sequences obtained from 155 ARV naive individuals from 2004 to 2009 were phylogenetically analysed. The overall rate of HIV-1 non-B infections was 31.0% (n = 48/155), increasing from 7.8% in 2004–2006 to 40.9% in 2009, and about one-third were identified as unique recombinant forms. CRF02_AG was the prevalent non-B clade (n = 28/4…

AdultMaleMicrobiology (medical)AdolescentPopulationHIV Infectionsnon-B subtypeBiologySettore MED/42 - Igiene Generale E ApplicataMicrobiologyCohort StudiesEvolution MolecularMolecular evolutionGeneticsCluster AnalysisHumansHIV-1 subtypes; non-B subtypes; CRF; Molecular evolution; HAART-naïve patientsChildEvolutionary dynamicseducationCladeSicilyMolecular BiologyPhylogenyEcology Evolution Behavior and SystematicsAgedMolecular Epidemiologyeducation.field_of_studyGenetic diversityHIV-1 subtypeChi-Square DistributionMolecular epidemiologyPhylogenetic treeHAART-naïve patientsStrain (biology)Infantvirus diseasesCRFMiddle AgedGenes polVirologyInfectious DiseasesChild PreschoolHIV-1Molecular evolutionFemale
researchProduct